title: The risk for myocardial infarction with cyclooxygenase-2 inhibitors.
authors.forename: Jeong A
authors.initials: JA
authors.lastname: Kim
authors.forename: Youn Seon
authors.initials: YS
authors.lastname: Choi
authors.forename: Dokyung
authors.initials: D
authors.lastname: Yoon
authors.forename: Kyung Hwan
authors.initials: KH
authors.lastname: Cho
mesh_terms: D001241:Aspirin / Q000008:administration & dosage; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000008:administration & dosage / Q000009:adverse effects*; D004347:Drug Interactions; D006801:Humans; D008565:Membrane Proteins; D009203:Myocardial Infarction / Q000139:chemically induced*; D011451:Prostaglandin-Endoperoxide Synthases / Q000008:administration & dosage / Q000009:adverse effects*; D012307:Risk Factors
chemical_list: D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D008565:Membrane Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases; D001241:Aspirin